Molecular Basis of Persister Awakening and Lag-Phase Recovery in Escherichia coli After Antibiotic Exposure
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27010467 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Karolina Stojowska-Swędrzyńska und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of General and Medical Biochemistry, Faculty of Biology, University of Gdańsk, Wita Stwosza 59, 80-308 Gdańsk, Poland. Hauptthemen laut MEDLINE: Escherichia coli, Anti-Bacterial Agents, Drug Resistance, Bacterial. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 132 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Centre, National Science Centre, Poland.
Abstract (Originalsprache)
Antibiotic persistence is a transient phenotype in which a subset of genetically susceptible bacteria survives lethal antibiotic exposure without acquiring resistance. However, survival alone does not define a persister cell—only cells that successfully recover, resume growth, and produce viable progeny complete the persister cycle. Recent studies in Escherichia coli show that persister awakening is a multistage process shaped by dormancy depth, metabolic state, and antibiotic-induced damage. Upstream induction mechanisms, including stringent-response signaling and toxin–antitoxin–mediated growth arrest, primarily determine dormancy depth but do not directly control awakening kinetics. During the lag phase, persister cells undergo coordinated recovery involving detoxification of residual antibiotics, ATP restoration, dissolution of protein aggregates, and ribosome reactivation. After exposure to fluoroquinolones, awakening additionally requires SOS-driven DNA repair via homologous recombination or transcription-coupled repair. In contrast, β-lactam–exposed persister cells rely mainly on efflux-mediated detoxification and asymmetric damage partitioning. Failure to restore proteostasis or resolve damage results in abortive recovery or cell death. Only after damage processing and metabolic reactivation can persister cells resume division and generate viable progeny. This review integrates current molecular insights into persister cell recovery in E. coli, highlighting the lag phase as the critical barrier between survival and true persistence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General and Medical Biochemistry, Faculty of Biology, University of Gdańsk, Wita Stwosza 59, 80-308 Gdańsk, Poland.
ORCID-Profile: Karolina Stojowska-Swędrzyńska, Ewa Laskowska, Dorota Kuczyńska-Wiśnik
Förderung
- National Science Centre
- National Science Centre, Poland
Zitieren
APA
Stojowska-Swędrzyńska, K., Laskowska, E., & Kuczyńska-Wiśnik, D. (2026). Molecular Basis of Persister Awakening and Lag-Phase Recovery in Escherichia coli After Antibiotic Exposure. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27010467
Vancouver
Stojowska-Swędrzyńska K, Laskowska E, Kuczyńska-Wiśnik D. Molecular Basis of Persister Awakening and Lag-Phase Recovery in Escherichia coli After Antibiotic Exposure. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27010467
BibTeX
@article{StojowskaSwdrzyska2026,
author = {Stojowska-Swędrzyńska, Karolina and Laskowska, Ewa and Kuczyńska-Wiśnik, Dorota},
title = {Molecular Basis of Persister Awakening and Lag-Phase Recovery in Escherichia coli After Antibiotic Exposure},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27010467}
}
EUVIMED